120 related articles for article (PubMed ID: 3163797)
1. An evaluation of CA125, CA1 and peanut lectin immunoreactivity in epithelial ovarian neoplasms: correlation with histopathological features, prognostic variables and patient outcome.
Friedlander M; Leary J; Russell P
Pathology; 1988 Jan; 20(1):38-44. PubMed ID: 3163797
[TBL] [Abstract][Full Text] [Related]
2. Antibody-antigen complex formation following injection of OC125 monoclonal antibody in patients with ovarian cancer.
Haisma HJ; Battaile A; Stradtman EW; Knapp RC; Zurawski VR
Int J Cancer; 1987 Dec; 40(6):758-62. PubMed ID: 3480271
[TBL] [Abstract][Full Text] [Related]
3. A study of the Ca antigen in epithelial tumours of the ovary.
Ferguson AM; Fox H
J Clin Pathol; 1984 Jan; 37(1):6-9. PubMed ID: 6368598
[TBL] [Abstract][Full Text] [Related]
4. Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass.
Hogdall EV; Høgdall CK; Tingulstad S; Hagen B; Nustad K; Xu FJ; Bast RC; Jacobs IJ
Int J Cancer; 2000 Nov; 89(6):519-23. PubMed ID: 11102897
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody, Mab 12C3, is a sensitive immunohistochemical marker of early malignant change in epithelial ovarian tumors.
Yamada K; Ohkawa K; Joh K
Am J Clin Pathol; 1995 Mar; 103(3):288-94. PubMed ID: 7872250
[TBL] [Abstract][Full Text] [Related]
6. Specificity of reagents directed to the Thomsen-Friedenreich antigen and their capacity to bind to the surface of human carcinoma cell lines.
Wolf MF; Koerner U; Schumacher K
Cancer Res; 1986 Apr; 46(4 Pt 1):1779-82. PubMed ID: 2418954
[TBL] [Abstract][Full Text] [Related]
7. A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II).
Nozawa S; Yajima M; Sasaki H; Tsukazaki K; Aoki D; Sakayori M; Udagawa Y; Kobayashi T; Sato I; Furusako S
Jpn J Cancer Res; 1991 Jul; 82(7):854-61. PubMed ID: 1715339
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma--comparison with CA125.
McGuckin MA; Layton GT; Bailey MJ; Hurst T; Khoo SK; Ward BG
Gynecol Oncol; 1990 May; 37(2):165-71. PubMed ID: 1693126
[TBL] [Abstract][Full Text] [Related]
9. An antibody-lectin sandwich assay for the determination of CA125 antigen in ovarian cancer patients.
Madiyalakan R; Kuzma M; Noujaim AA; Suresh MR
Glycoconj J; 1996 Aug; 13(4):513-7. PubMed ID: 8872106
[TBL] [Abstract][Full Text] [Related]
10. Use of immunohistochemical staining panel for characterisation of ovarian neoplasms.
Ashorn P; Helle M; Helin H; Ashorn R; Krohn K
J Clin Pathol; 1988 Jan; 41(1):12-6. PubMed ID: 2449464
[TBL] [Abstract][Full Text] [Related]
11. Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.
Macdonald F; Bird R; Stokes H; Russell B; Crocker J
J Clin Pathol; 1988 Mar; 41(3):260-4. PubMed ID: 3162916
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
Cruickshank DJ; Fullerton WT; Klopper A
Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
[TBL] [Abstract][Full Text] [Related]
13. [CA125 and radioimmunoimaging in monitoring of epithelial ovarian carcinoma].
Yu Q; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 1991 Jul; 26(4):235-8, 252. PubMed ID: 1914661
[TBL] [Abstract][Full Text] [Related]
14. Tumor antigen NB/70K and CA 125 levels in the blood of preoperative ovarian cancer patients and controls: a preliminary report of the use of the NB12123 and CA 125 radioimmunoassays alone and in combination.
Knauf S; Bast RC
Int J Biol Markers; 1988; 3(2):75-81. PubMed ID: 3243980
[TBL] [Abstract][Full Text] [Related]
15. A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer.
Dhokia B; Canney PA; Pectasides D; Munro AJ; Moore M; Wilkinson PM; Self C; Epenetos AA
Br J Cancer; 1986 Dec; 54(6):891-5. PubMed ID: 3467785
[TBL] [Abstract][Full Text] [Related]
16. CA125 serum levels and secondary laparotomy in epithelial ovarian tumours.
Rome RM; Koh H; Fortune D; Cauchi M
Aust N Z J Obstet Gynaecol; 1987 May; 27(2):142-5. PubMed ID: 3479113
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium.
Chang K; Pastan I; Willingham MC
Int J Cancer; 1992 Feb; 50(3):373-81. PubMed ID: 1735605
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical identification of CA125 and the F(ab')2 fragments of the murine monoclonal antibody OC125 in ovarian cancer tissue.
Ronay G; Jäger W; Weiss K; Feistel H; Wolf F; Tulusan AH; Lang N
Br J Cancer Suppl; 1990 Jul; 10():67-9. PubMed ID: 2200498
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
[TBL] [Abstract][Full Text] [Related]
20. Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers.
Kobayashi H; Ohi H; Fujii T; Terao T
Br J Cancer; 1993 Feb; 67(2):237-43. PubMed ID: 7679280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
